Annexin A11 抗体 (AA 1-505)
Quick Overview for Annexin A11 抗体 (AA 1-505) (ABIN296652)
抗原
See all Annexin A11 (ANXA11) 抗体适用
宿主
克隆类型
标记
应用范围
- 
    - 
                                            抗原表位
- AA 1-505
- 
                                            特异性
- Detects endogenous human, mouse, and rat Annexin A11 on Western Blots. Does not cross-react with recombinant human Annexin A1, A2, A3, A4, A5, A6, A7, A8, A9, A10, or A13 in Western Blots.
- 
                                            纯化方法
- Immunoaffinity purified
- 
                                            免疫原
- E. coli derived recombinant human Annexin A11 (aa1-505).
- 
                                            亚型
- IgG
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- 
                        Approved: WB
 Usage: Western Blot: An antibody concentration of 1.0 μg/mL is recommended.
- 
                                            说明
- 
                        Target Species of Antibody: Human 
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Lyophilized
- 
                                            溶解方式
- deionized water
- 
                                            浓度
- Lot specific
- 
                                            缓冲液
- Lyophilized.
 
- 
                                            
- 
    - Annexin A11 (ANXA11)
- 
                                            别名
- ANXA11 / Annexin XI
- 
                                            背景
- 
                        Name/Gene ID: ANXA11
 Synonyms: ANXA11, 56 kDa autoantigen, Annexin A11, Annexin XI, CAP-50, Annexin-11, ANX11, Autoantigen, 56-kD, CAP50
- 
                                            基因ID
- 311
- 
                                            UniProt
- P50995
 抗原
- 
                    
 
                                     
                                     
                                    